Preston Heather 4
4 · Akouos, Inc. · Filed Jul 2, 2020
Insider Transaction Report
Form 4
Akouos, Inc.AKUS
Preston Heather
Director
Transactions
- Purchase
Common Stock
2020-06-30$17.00/sh+294,117$4,999,989→ 1,794,088 total(indirect: See Footnote) - Conversion
Common Stock
2020-06-30+1,499,971→ 1,499,971 total(indirect: See Footnote) - Purchase
Common Stock
2020-06-30$17.00/sh+5,882$99,994→ 5,882 total - Conversion
Series B Preferred Stock
2020-06-30−1,499,971→ 0 total(indirect: See Footnote)→ Common Stock (1,499,971 underlying)
Footnotes (2)
- [F1]On June 30, 2020, the Series B Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- [F2]The reportable securities are owned directly by Pivotal bioVenture Partners Fund I, L.P. ("Pivotal"). The Reporting Person is a managing partner of Pivotal bioVenture Partners Management Ltd. ("Investment Advisor"), which is the investment advisor to Pivotal, and is managing partner of Pivotal bioVenture Partners Investment Advisor, LLC, which is the U.S. sub-advisor to the Investment Advisor. Therefore, the Reporting Person may be deemed to beneficially own the shares held by Pivotal. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of the Reporting Person's pecuniary interest therein, if any.